MarketCap
Facebook
X
TelegramShineco, Inc. DSO | TYHT
DSO Jährlich Shineco, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 172 | 115 | 132 | 177 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 177 | 115 | 149 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agios Pharmaceuticals
AGIO
|
56.1 | $ 31.77 | 1.23 % | $ 1.84 B |  USA |
 |
Cue Biopharma
CUE
|
43.1 | $ 18.89 | -6.21 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
16.6 | $ 1.45 | -3.33 % | $ 83.1 M | USA |
 |
Abeona Therapeutics
ABEO
|
0.000094 | $ 2.46 | -3.35 % | $ 130 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
37.5 | $ 18.13 | 9.85 % | $ 3.05 B | USA |
 |
Atossa Therapeutics
ATOS
|
207 | $ 2.21 | 3.76 % | $ 19 M | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
16 | - | -7.31 % | $ 49 M | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
2.35 | - | - | $ 1.77 B | USA |
 |
ADC Therapeutics SA
ADCT
|
111 | $ 1.51 | -9.88 % | $ 192 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
37.8 | $ 33.57 | -0.62 % | $ 1.93 B | USA |
 |
Ardelyx
ARDX
|
58 | $ 3.0 | 2.39 % | $ 723 M | USA |
 |
Akebia Therapeutics
AKBA
|
62.9 | $ 0.54 | 1.8 % | $ 139 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
56.6 | $ 21.39 | 0.52 % | $ 6.7 B | USA |
 |
Phathom Pharmaceuticals
PHAT
|
122 | $ 5.45 | 2.16 % | $ 397 M | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
50 | $ 3.8 | 2.15 % | $ 728 M |  Canada |
 |
Agenus
AGEN
|
3.58 | $ 7.02 | -1.82 % | $ 209 M | USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 12.44 | -0.52 % | $ 3.72 B | Canada |
 |
Aptevo Therapeutics
APVO
|
79 | $ 1.08 | -4.42 % | $ 341 K | USA |
 |
Aclaris Therapeutics
ACRS
|
7.42 | $ 4.13 | -2.5 % | $ 506 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
60.7 | $ 29.38 | -2.91 % | $ 4.46 B | USA |
 |
Biofrontera AG
BFRA
|
42.2 | - | -8.24 % | $ 105 M |  Germany |
 |
Pliant Therapeutics
PLRX
|
229 | $ 0.78 | -2.19 % | $ 47.9 M | USA |
 |
Capricor Therapeutics
CAPR
|
31.9 | $ 8.91 | -9.54 % | $ 414 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 29.06 | -1.09 % | $ 1.36 B | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
106 | - | 1.68 % | $ 4.65 B |  China |
 |
Aquestive Therapeutics
AQST
|
103 | $ 3.52 | -0.56 % | $ 376 M | USA |
 |
Jaguar Health
JAGX
|
48.3 | $ 0.44 | -0.21 % | $ 1.03 M | USA |
 |
Arvinas
ARVN
|
4.66 | $ 6.9 | 2.07 % | $ 489 M | USA |
 |
Cerus Corporation
CERS
|
47 | $ 1.95 | -6.04 % | $ 372 M | USA |
 |
Pulmatrix
PULM
|
21.7 | $ 1.39 | 2.58 % | $ 5.08 B | USA |
 |
Fortress Biotech
FBIO
|
115 | $ 1.9 | -4.52 % | $ 53 M | USA |
 |
Inhibrx
INBX
|
24.6 | $ 90.63 | -1.21 % | $ 4.27 B | USA |
 |
Entera Bio Ltd.
ENTX
|
548 | $ 3.24 | -0.31 % | $ 150 M |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
129 | - | - | $ 459 M | USA |
 |
Legend Biotech Corporation
LEGN
|
3.53 K | $ 20.25 | -16.63 % | $ 7.46 B | USA |
 |
CytomX Therapeutics
CTMX
|
12.3 | $ 2.0 | 0.76 % | $ 276 M | USA |
 |
Krystal Biotech
KRYS
|
109 | $ 306.47 | 1.13 % | $ 8.87 B | USA |
 |
Kura Oncology
KURA
|
29.4 | $ 7.56 | -0.13 % | $ 663 M | USA |
 |
Inhibikase Therapeutics
IKT
|
27.9 | $ 1.58 | -6.25 % | $ 155 M | USA |